These collective studies indicate that there is heterogeneity in lupus across different disease models, with some reliant on G‐CSF signaling, some protected by exogenous G‐CSF treatment, and others seemingly independent of this growth factor. Here, CSF3 is linked to systemic lupus erythematosus.